Eliem Therapeutics (ELYM) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free ELYM Stock Alerts $2.76 +0.05 (+1.85%) (As of 03/27/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHere's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situationfinance.yahoo.com - March 6 at 4:17 PMSilverarc Capital Management LLC Lowers Holdings in Eliem Therapeutics, Inc. (NASDAQ:ELYM)marketbeat.com - February 18 at 12:54 PMEliem Therapeutics (NASDAQ:ELYM) Shares Up 3.5%marketbeat.com - February 3 at 2:11 AMCheckpoint Therapeutics Inc CKPTmorningstar.com - November 19 at 9:35 AMEliem Therapeutics Inc ELYMmorningstar.com - November 15 at 8:05 PMEliem Therapeutics (NASDAQ:ELYM) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - September 28 at 2:00 PMEliem (ELYM) to Explore Strategic Options, Stock Rises 6%finance.yahoo.com - July 21 at 12:26 PMEliem Therapeutics’ stock soars 21% premarket after company says it may sell itselfmsn.com - July 21 at 7:26 AMWhat's Happening With Eliem Therapeutics Shares Today?benzinga.com - July 20 at 3:37 PMEliem Therapeutics, Inc.: Eliem Therapeutics Announces Plans to Explore Strategic Alternativesfinanznachrichten.de - July 20 at 10:22 AMEliem Therapeutics Shares Rally Premarket on Exploration of Options >ELYMmarketwatch.com - July 20 at 10:22 AMWhy Is Eliem Therapeutics (ELYM) Stock Up 6% Today?markets.businessinsider.com - July 20 at 10:22 AMEliem Therapeutics Announces Plans to Explore Strategic Alternativesfinance.yahoo.com - July 20 at 10:22 AMStifel Nicolaus Sticks to Its Buy Rating for Eliem Therapeutics (ELYM)markets.businessinsider.com - June 7 at 2:29 AMStifel Nicolaus Reaffirms Their Buy Rating on Eliem Therapeutics (ELYM)markets.businessinsider.com - May 25 at 8:00 AMEliem Therapeutics, Inc.: Eliem Therapeutics Reports First Quarter Financial Results and Business Highlightsfinanznachrichten.de - May 12 at 10:15 AMEliem Therapeutics GAAP EPS of -$0.84seekingalpha.com - May 11 at 8:03 PMEliem Therapeutics Reports First Quarter Financial Results and Business Highlightsfinance.yahoo.com - May 11 at 8:03 PMmarketbeat.com - May 5 at 10:03 AMWe're Hopeful That Eliem Therapeutics (NASDAQ:ELYM) Will Use Its Cash Wiselyfinance.yahoo.com - April 21 at 4:15 PMSVB Securities Keeps Their Buy Rating on Eliem Therapeutics (ELYM)markets.businessinsider.com - March 9 at 3:05 AMEliem Therapeutics, Inc.: Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlightsfinanznachrichten.de - March 7 at 5:40 AMEliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlightsfinance.yahoo.com - March 6 at 7:39 PMELYM Eliem Therapeutics, Inc.seekingalpha.com - February 23 at 6:33 PMEliem Therapeutics slashing staff amid leadership shakeupfinance.yahoo.com - February 23 at 2:52 AMEliem Pauses Development On Depression Drug, Lays Off 55% Workforcefinance.yahoo.com - February 18 at 10:23 AMEliem Therapeutics down after announcing reprioritization plans, layoffsmsn.com - February 10 at 9:10 AMEliem Therapeutics Provides Strategic Update and Announces Leadership Transitionfinance.yahoo.com - February 9 at 6:06 PMmarketbeat.com - February 9 at 4:06 PMmarketbeat.com - February 6 at 9:51 AMEliem Therapeutics, Inc. (NASDAQ:ELYM) Short Interest Updatemarketbeat.com - January 27 at 5:20 PMEliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conferencefinance.yahoo.com - November 30 at 8:06 AMEliem Therapeutics, Inc.: Eliem Therapeutics Reports Third Quarter Financial and Business Highlightsfinanznachrichten.de - November 14 at 12:03 PMIs Eliem Therapeutics (NASDAQ:ELYM) In A Good Position To Invest In Growth?finance.yahoo.com - November 12 at 11:04 AMEliem Therapeutics to Participate at Two Upcoming Investor Conferencesfinance.yahoo.com - November 8 at 9:59 AMEliem Therapeutics (ELYM) Investor Presentation - Slideshowseekingalpha.com - August 18 at 6:51 PMEliem Therapeutics: Q2 Earnings Insightsmsn.com - August 15 at 11:56 AMEliem Therapeutics Reports Second Quarter Financial and Business Highlightsfinance.yahoo.com - August 15 at 11:56 AMEliem Therapeutics Discontinues ETX-810 Program As Phase 2a Trial In Sciatica Failsnasdaq.com - August 2 at 1:27 PMEliem Therapeutics Shares Fall On Lower Back Pain Trial Setbackfinance.yahoo.com - August 2 at 1:27 PMEliem's stock slides 20% after saying it will discontinue development of pain treatmentfinance.yahoo.com - August 2 at 1:27 PMEliem Therapeutics Scraps Lead Candidate After Study Failure >ELYMmarketwatch.com - August 2 at 8:26 AMEliem Therapeutics Provides ETX-810 Program Updatefinance.yahoo.com - August 2 at 8:26 AMmarketbeat.com - August 2 at 6:57 AMmarketbeat.com - July 13 at 1:24 PMSVB Leerink Maintains Outperform Rating for Eliem Therapeutics: Here's What You Need To Knowmarkets.businessinsider.com - July 11 at 7:32 PMEliem Therapeutics to Host Virtual Investor Event on July 21, 2022finance.yahoo.com - July 7 at 7:49 AMEliem Therapeutics Announces Last Patient Completed Dosing in Phase 2a Study of ETX-810 in Patients with Lumbosacral Radicular Pain (LSRP)finance.yahoo.com - June 27 at 6:09 PMHarpoon Therapeutics, Grove top healthcare gainers; Chimerix, Eliem lead losers' packseekingalpha.com - May 17 at 8:59 PMEliem Therapeutics Reports First Quarter Financial and Business Highlightsfinance.yahoo.com - May 16 at 9:03 AM Get Eliem Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ELYM and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… ELYM Media Mentions By Week ELYM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELYM News Sentiment▼0.430.61▲Average Medical News Sentiment ELYM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELYM Articles This Week▼20▲ELYM Articles Average Week Get Eliem Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ELYM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Affimed News Oncolytics Biotech News Enlivex Therapeutics News InflaRx News Rezolute News Immuneering News Reviva Pharmaceuticals News Lantern Pharma News Tempest Therapeutics News Aclaris Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELYM) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eliem Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.